India’s First Dengue Vaccine Gets Green Light: A Breakthrough in Public Health

CDSCO grants marketing authorisation for India’s first dengue vaccine, a significant milestone in the fight against this mosquito-borne disease.

Gates Medical Research Institute, Serum Institute Partner to Manufacture Groundbreaking TB Vaccine

The Gates Medical Research Institute and Serum Institute of India collaborate to develop and manufacture a novel TB vaccine. Discover the latest advancements in

Review Confirms mRNA Vaccines Protect Against Severe Infectious Diseases – The Indian Practitioner

Discover the latest findings on mRNA vaccines and their effectiveness in protecting against severe infectious diseases, backed by expert analysis from The India

Serum Institute of India to Manufacture Oxford Ebola Vaccine Backed by US$ 8.6 Million CEPI Funding – IBEF

Learn about the Serum Institute of India manufacturing the Oxford Ebola vaccine, backed by US$ 8.6 million CEPI funding, and its significance in global health.

Ebola Vaccine Race: Can Africa Keep Up with the Outbreak?

The Ebola outbreak is outpacing the response, with Africa racing against time to develop an effective vaccine. We explore the challenges and opportunities in th

Moderna and CEPI Expand Collaboration to Include Bundibugyo Ebolavirus Vaccine

Moderna and CEPI expand collaboration to include development of vaccine against Bundibugyo ebolavirus, a highly infectious and deadly virus.

African Union’s Health Agency Vows to Deliver Ebola Bundibugyo Vaccine by 2026

Learn about the African Union’s health agency’s commitment to deliver the Ebola Bundibugyo vaccine by the end of 2026 and its implications for global health.

RSS
Follow by Email
X (Twitter)
WhatsApp
Copy link
URL has been copied successfully!